Completed
Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions
NCT01414426
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +10 more
- Locations
-
- University of Chicago Chicago, Illinois, United States